Xingnaojing injection
2014BAI10B05-01
Approved small_molecule active
Quick answer
Xingnaojing injection for Acute Ischemic Stroke is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Acute Ischemic Stroke
- Phase
- Approved
- Modality
- small_molecule
- Status
- active